Panel Discussion: Understanding Genetically Targeted Drug Technologies

Description: A discussion between researchers and DIAD family members about the future of CRISPR and other genetic therapies, including both their therapeutic potential and the risks associated with them
Runtime: 00:38:00

Speaker: Eric McDade, DO
Speaker title: DIAN Trials Unit Co-Director
Speaker organization: Washington University in St. Louis

Speaker: Bret Bostwick, MD
Speaker title: Director, Clinical Research
Speaker organization: Alnylam Pharmaceuticals

Speaker: Alicia Brasch
Speaker organization: Youngtimers

Speaker: Cath Mummery, MD
Speaker title: Head of Clinical Trials in Dementia
Speaker organization: University College London

Speaker: Selina Wray, PhD
Speaker title: Senior Research Fellow
Speaker organization: University College London

Speaker: Subhojit Roy, MD, PhD
Speaker title: Professor of Pathology and Neurosciences
Speaker organization: University of California, San Diego

Event: 2023 Regional DIAD Family Conference: A New Era
Location: Amsterdam, Netherlands
Year: 2023

Search tags: CRISPR, DNA, RNA, tau ASOs, CSF, cerebrospinal fluid, drug targets, regulation, disease modeling, risk and safety, siRNA, clinical trials, APP, preclinical Alzheimer’s, research participation, ethics, amyloid plaques, amyloid beta